This prompted us to speculate that serum cTnT levels might have an unexpected, informative value for establishing the diagnosis and prognosis of ALS, especially if cTnI is measured simultaneously to control for potentially undetected myocardial injury. The gene discussed is TNNI3; the disease is amyotrophic lateral sclerosis.